Download Sample
Add to CartGlobal Hydronephrosis Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Treatment;
Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, and Others.By Type;
Unilateral Hydronephrosis and Bilateral Hydronephrosis.By Diagnosis;
Laboratory Test - Urinalysis, Complete Blood Count, Electrolyte Analysis & Others, Imaging - CT Scan, Ultrasound, Intravenous Pyelography, KUB X-Rays, and Others.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).Introduction
Global Hydronephrosis Market (USD Million), 2021 - 2031
In the year 2024, the Global Hydronephrosis Market was valued at USD 220.24 million. The size of this market is expected to increase to USD 429.18 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 10.0%.
The global hydronephrosis market is experiencing significant growth driven by various factors such as increasing prevalence of urinary tract obstructions, advancements in diagnostic techniques, and rising healthcare expenditure worldwide. Hydronephrosis, characterized by the swelling of the kidney due to urine buildup, can result from various causes including kidney stones, tumors, or congenital abnormalities. As awareness about urinary tract conditions grows and screening methods improve, more cases of hydronephrosis are being diagnosed early, driving market expansion.
Technological advancements in medical imaging and diagnostics are also propelling the hydronephrosis market forward. Non-invasive imaging techniques such as ultrasound, CT scans, and MRI allow for accurate diagnosis and monitoring of hydronephrosis, leading to timely intervention and improved patient outcomes. Additionally, the development of minimally invasive surgical procedures for treating urinary tract obstructions, such as ureteroscopy and percutaneous nephrostomy, is reducing the need for traditional open surgeries, thereby driving market growth.
The increasing prevalence of risk factors such as kidney stones, urinary tract infections, and prostate enlargement is contributing to the growth of the hydronephrosis market. Lifestyle factors such as sedentary lifestyles, poor dietary habits, and increasing geriatric population are also driving the incidence of urinary tract obstructions. As healthcare systems worldwide continue to prioritize the management of urological conditions, the demand for effective diagnostic tools and treatment options for hydronephrosis is expected to rise, further fueling market expansion.
Global Hydronephrosis Market Recent Developments
-
In June 2023, Novartis AG bolstered its innovative medicines strategy and renal pipeline by acquiring Chinook Therapeutics. This acquisition may expand the company’s drug portfolio to target kidney disease treatment.
-
In August 2023, Novartis announced the successful acquisition of Chinook Therapeutics, Inc., a biopharmaceutical company headquartered in Seattle, WA. Chinook Therapeutics specializes in the research, development, and commercialization of precision medicines targeting kidney diseases.
Segment Analysis
The global hydronephrosis market has been segmented based on type, diagnosis, and geography, reflecting the diverse nature of this condition and the need for tailored approaches to diagnosis and treatment. In terms of type, hydronephrosis can be classified based on its underlying causes, such as obstructive or non-obstructive hydronephrosis. Obstructive hydronephrosis, often caused by kidney stones, tumors, or congenital abnormalities, accounts for a significant portion of cases and typically requires intervention to alleviate urinary tract obstructions. Non-obstructive hydronephrosis, on the other hand, may result from conditions like vesicoureteral reflux or pregnancy and may not always require immediate treatment.The Global Hydronephrosis Market has been segmented by Treatment into Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, and Others.
Diagnosis plays a crucial role in the management of hydronephrosis, and the market segmentation reflects the various diagnostic modalities available. Common diagnostic techniques include imaging studies such as ultrasound, CT scans, and MRI, which allow healthcare providers to visualize the kidney and urinary tract anatomy and assess the extent of hydronephrosis. Additionally, urodynamic studies and laboratory tests may be performed to evaluate kidney function and identify underlying causes of urinary tract obstructions. The segmentation by diagnosis underscores the importance of accurate and comprehensive assessment in guiding treatment decisions and optimizing patient outcomes.
Geographically, the global hydronephrosis market exhibits variations in prevalence, healthcare infrastructure, and access to diagnostic and treatment services. Regions with higher incidences of risk factors for hydronephrosis, such as kidney stones or urinary tract infections, may have a greater demand for diagnostic and treatment options. Additionally, disparities in healthcare access and resources may influence market dynamics, with opportunities for growth in regions investing in improving urological care infrastructure and expanding access to advanced diagnostic technologies and minimally invasive treatment options. As such, market segmentation by geography allows for targeted strategies to address the unique needs and challenges faced by different regions in managing hydronephrosis effectively.
Global Hydronephrosis Segment Analysis
In this report, the Global Hydronephrosis Market has been segmented by Treatment, Type, Diagnosis and Geography.
Global Hydronephrosis Market, Segmentation by Treatment
The Global Hydronephrosis Market has been segmented by Treatment into Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy, and Others.
Shock wave lithotripsy is a non-invasive treatment commonly used for breaking up kidney stones that may cause obstruction, thereby relieving pressure on the kidneys and improving urine flow. Laparoscopy, a minimally invasive surgical procedure, is used to remove blockages or treat underlying conditions contributing to hydronephrosis, offering faster recovery times and reduced risk compared to traditional surgery. Bladder catheterization involves the insertion of a tube into the bladder to drain urine and relieve pressure on the kidneys, commonly used in cases of urinary retention.
Steroid therapy is used in certain cases of hydronephrosis to reduce inflammation and swelling, particularly when the condition is caused by an inflammatory disease or injury. The Others category includes additional treatments such as medication to manage infections or underlying conditions, as well as surgical interventions like nephrectomy or drainage procedures in severe cases. These treatment options are crucial in managing hydronephrosis, with each targeting the specific causes and symptoms of the condition to improve kidney function and prevent complications.
Global Hydronephrosis Market, Segmentation by Type
The Global Hydronephrosis Market has been segmented by Type into Unilateral Hydronephrosis and Bilateral Hydronephrosis.
The global hydronephrosis market is segmented by type into unilateral hydronephrosis and bilateral hydronephrosis, each presenting unique challenges and opportunities for the healthcare industry. Unilateral hydronephrosis refers to the dilation of one kidney due to obstruction or blockage in the urinary tract on one side. This condition can arise from various factors such as kidney stones, tumors, or congenital abnormalities. Treatment strategies for unilateral hydronephrosis typically involve addressing the underlying cause of obstruction, such as surgical intervention or medical management, depending on the severity of the condition and the patient's overall health status.
Bilateral hydronephrosis involves the dilation of both kidneys, posing a more complex clinical scenario. Bilateral hydronephrosis can result from systemic conditions such as bladder outlet obstruction, neurogenic bladder, or conditions affecting both ureters simultaneously. Managing bilateral hydronephrosis requires a comprehensive approach, often involving a combination of medical therapies, surgical interventions, and close monitoring of renal function. The treatment plan may vary depending on the underlying cause, the extent of kidney damage, and the patient's overall health condition. Despite the challenges associated with bilateral hydronephrosis, advancements in medical technology and multidisciplinary approaches have improved outcomes for patients with this condition.
Understanding the distinct characteristics and treatment approaches for unilateral and bilateral hydronephrosis is essential for healthcare providers to effectively manage patients with these conditions. As diagnostic techniques continue to evolve and treatment modalities advance, the global hydronephrosis market is expected to witness continued growth, driven by the increasing prevalence of urinary tract obstructions and the growing emphasis on personalized and targeted therapies. Collaborative efforts between healthcare professionals, researchers, and industry stakeholders will play a crucial role in addressing the unmet needs of patients with hydronephrosis and driving innovation in the field of urology and nephrology.
Global Hydronephrosis Market, Segmentation by Diagnosis
The Global Hydronephrosis Market has been segmented by Diagnosis into Laboratory Test and Imaging.
The global hydronephrosis market, segmented by diagnosis into laboratory tests and imaging, reflects a comprehensive approach to identifying and evaluating urinary tract obstructions. Laboratory tests play a crucial role in the initial assessment of hydronephrosis, aiding in the detection of underlying conditions such as urinary tract infections, electrolyte imbalances, or kidney function abnormalities. These tests typically include urinalysis, blood tests to assess kidney function, and biomarker assays to identify specific underlying causes. By providing valuable insights into the patient's overall health and the potential causes of hydronephrosis, laboratory diagnostics guide further clinical management and treatment decisions.
In addition to laboratory tests, imaging techniques constitute a cornerstone in the diagnosis and monitoring of hydronephrosis. Imaging modalities such as ultrasound, computed tomography (CT) scans, magnetic resonance imaging (MRI), and intravenous pyelogram (IVP) offer detailed visualization of the urinary tract structures, allowing for the precise identification of obstructions and the extent of kidney swelling. These non-invasive imaging tools provide clinicians with essential information for accurate diagnosis, treatment planning, and follow-up assessments. Moreover, advancements in imaging technologies have improved diagnostic accuracy, reduced radiation exposure, and enhanced patient comfort, further driving the adoption of imaging-based diagnostics in the global hydronephrosis market.
The segmentation of the global hydronephrosis market into laboratory tests and imaging reflects the multifaceted approach required for comprehensive diagnosis and management of urinary tract obstructions. While laboratory tests offer insights into systemic conditions and underlying causes, imaging modalities provide detailed anatomical information essential for precise localization and characterization of obstructions. As healthcare systems worldwide prioritize early detection and effective management of hydronephrosis, the integration of both laboratory diagnostics and advanced imaging techniques into routine clinical practice is essential for optimizing patient outcomes and driving market growth.
Global Hydronephrosis Market, Segmentation by Geography
In this report, the Global Hydronephrosis Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Hydronephrosis Market Share (%), by Geographical Region, 2024
In the global hydronephrosis market, geographical region plays a significant role in determining market share. North America holds a considerable portion of the market share, attributed to factors such as well-established healthcare infrastructure, high healthcare expenditure, and early adoption of advanced medical technologies. Additionally, the region benefits from a large patient pool with urinary tract obstructions due to lifestyle factors, aging population, and prevalence of conditions such as kidney stones and prostate enlargement. With a robust presence of key market players and ongoing technological advancements, North America is expected to maintain a significant market share in the hydronephrosis market.
Europe follows closely behind North America in terms of market share in the global hydronephrosis market. The region boasts advanced healthcare systems, extensive research and development activities, and favorable reimbursement policies, contributing to market growth. Increasing awareness about urological conditions, rising geriatric population, and proactive government initiatives for improving healthcare services further drive the demand for diagnostic and treatment options for hydronephrosis in Europe. However, market dynamics may vary across European countries due to differences in healthcare policies, economic conditions, and population demographics.
Asia Pacific is emerging as a lucrative market for hydronephrosis, witnessing rapid growth in market share. Factors such as increasing healthcare expenditure, improving healthcare infrastructure, and rising prevalence of urinary tract obstructions in countries like China, India, and Japan contribute to market expansion. Moreover, growing awareness about urological conditions, rising disposable income, and adoption of advanced medical technologies are driving the demand for diagnostic and treatment options for hydronephrosis in the region. As healthcare systems in Asia Pacific continue to evolve and address the unmet medical needs, the region is expected to experience significant growth and gain a larger market share in the global hydronephrosis market.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Hydronephrosis Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Prevalence of Urinary Tract Obstructions
- Advancements in Diagnostic Technologies
-
Growing Healthcare Expenditure-The global hydronephrosis market is experiencing significant growth, fueled in part by the increasing healthcare expenditure worldwide. As healthcare systems around the globe allocate more resources to address urological conditions, including hydronephrosis, patients benefit from improved access to diagnostic tools, treatment options, and specialized care. This growing investment in healthcare infrastructure enables earlier detection and intervention for hydronephrosis, leading to better patient outcomes and reduced long-term healthcare costs associated with complications.
The rising healthcare expenditure contributes to advancements in medical technology and innovation, which further drive the growth of the hydronephrosis market. Healthcare providers are investing in state-of-the-art diagnostic imaging techniques and minimally invasive surgical procedures for the management of urinary tract obstructions, enhancing the accuracy of diagnosis and improving treatment outcomes. Additionally, increased funding for research and development in urology fosters the development of novel therapies and interventions, providing patients with more effective and less invasive treatment options.
As healthcare expenditure continues to grow, there is greater emphasis on preventive care and population health management, which includes initiatives to raise awareness about urological conditions like hydronephrosis. Public health campaigns and screening programs aimed at early detection and management of urinary tract obstructions help reduce the overall burden of the disease on healthcare systems. By investing in preventive measures and promoting healthy lifestyles, healthcare expenditure contributes to the overall improvement of patient health and quality of life, driving sustained growth in the global hydronephrosis market.
Restraints
- Limited Access to Healthcare in Some Regions
- High Treatment Costs
-
Potential Complications of Treatment-Complications associated with the treatment of hydronephrosis pose significant challenges to patients and healthcare providers alike. While interventions such as surgical correction of urinary tract obstructions or placement of stents are essential for relieving kidney swelling and restoring normal urinary flow, they carry inherent risks. One common complication is infection, which can occur postoperatively or as a result of urinary stent placement. Infections can lead to fever, pain, and in severe cases, sepsis, necessitating prompt medical intervention. Additionally, complications such as bleeding, injury to surrounding organs, or urinary leakage may occur during surgical procedures, highlighting the importance of skilled surgical techniques and careful postoperative monitoring.
The presence of comorbidities can increase the risk of complications associated with hydronephrosis treatment. Patients with underlying conditions such as diabetes, hypertension, or renal insufficiency may have compromised immune systems or impaired healing capacity, making them more susceptible to postoperative infections or delayed recovery. Furthermore, the elderly population, who are more likely to develop hydronephrosis due to age-related changes in the urinary tract, may be at increased risk of treatment-related complications due to frailty and reduced physiological reserve. Healthcare providers must carefully assess each patient's medical history and individual risk factors to minimize the likelihood of adverse events during treatment.
Complications related to long-term management of hydronephrosis, such as recurrent urinary tract infections or stent-related discomfort, can impact patient quality of life and adherence to treatment regimens. Stent encrustation or blockage, a common occurrence in patients with indwelling ureteral stents, may necessitate additional interventions such as stent replacement or removal, leading to increased healthcare utilization and costs. Moreover, prolonged exposure to urinary stents or frequent urinary tract infections can contribute to chronic kidney damage or renal scarring, highlighting the importance of vigilant monitoring and proactive management of complications in patients with hydronephrosis. Effective communication between patients and healthcare providers is essential to address concerns related to treatment complications and optimize patient outcomes in the management of hydronephrosis.
Opportunities
- Technological Advancements in Minimally Invasive Procedures
- Rising Awareness and Screening Initiatives
-
Expanding Geriatric Population-The expanding geriatric population is a significant driver of growth in the global hydronephrosis market. With aging, individuals are more susceptible to various medical conditions, including urinary tract obstructions that can lead to hydronephrosis. As the world's population ages, the prevalence of age-related factors such as enlarged prostate glands, kidney stones, and other urinary tract abnormalities increases, contributing to the rising incidence of hydronephrosis among older adults. This demographic trend creates a substantial market opportunity for diagnostic and therapeutic interventions targeting hydronephrosis.
The aging population often presents with multiple comorbidities, necessitating comprehensive and timely management of conditions such as hydronephrosis. Healthcare systems are increasingly focusing on providing specialized care for the elderly population, including the diagnosis and treatment of urological disorders like hydronephrosis. As a result, there is a growing demand for advanced diagnostic tools and minimally invasive treatment options that cater to the unique needs of older adults, driving innovation and investment in the hydronephrosis market.
Lifestyle factors associated with aging, such as sedentary habits and dietary choices, can contribute to the development or exacerbation of urinary tract obstructions leading to hydronephrosis. Public health initiatives aimed at promoting healthy aging and preventing chronic conditions are thus becoming increasingly important. By addressing modifiable risk factors and raising awareness about the importance of regular health screenings, these initiatives have the potential to mitigate the burden of hydronephrosis and other age-related urological conditions, creating further opportunities for market growth in the global hydronephrosis market.
Competitive Landscape Analysis
Key players in Global Hydronephrosis Market include:
- Boston Scientific Corporation
- Cook Medical
- Medtronic plc
- Baxter International Inc.
- Olympus Corporation
- KARL STORZ SE & Co. KG
- B. Braun Melsungen AG
- Stryker Corporation
- Coloplast Group
- Teleflex Incorporated
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Treatment
- Market Snapshot, By Type
- Market Snapshot, By Diagnosis
- Market Snapshot, By Region
- Global Hydronephrosis Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing Prevalence of Urinary Tract Obstructions
- Advancements in Diagnostic Technologies
- Growing Healthcare Expenditure
- Restraints
- Limited Access to Healthcare in Some Regions
- High Treatment Costs
- Potential Complications of Treatment
- Opportunities
- Technological Advancements in Minimally Invasive Procedures
- Rising Awareness and Screening Initiatives
- Expanding Geriatric Population
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Hydronephrosis Market, By Treatment, 2021 - 2031 (USD Million)
- Shock Wave Lithotripsy
- Laparoscopy
- Bladder Catheterization
- Steroid Therapy
- Others
- Global Hydronephrosis Market, By Type, 2021 - 2031 (USD Million)
- Unilateral Hydronephrosis
- Bilateral Hydronephrosis
- Global Hydronephrosis Market, By Diagnosis, 2021 - 2031 (USD Million)
- Laboratory Test
- Urinalysis
- Complete Blood Count
- Electrolyte Analysis
- Others
- Imaging
- CT Scan
- Ultrasound
- Intravenous Pyelography
- KUB X-Rays
- Others
- Laboratory Test
- Global Hydronephrosis Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Hydronephrosis Market, By Treatment, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- Boston Scientific Corporation
- Cook Medical
- Medtronic plc
- Baxter International Inc.
- Olympus Corporation
- KARL STORZ SE & Co. KG
- B. Braun Melsungen AG
- Stryker Corporation
- Coloplast Group
- Teleflex Incorporate
- Company Profiles
- Analyst Views
- Future Outlook of the Market